FDA Import Refusal AEK-0046386-8/10003/1 — Eli Lilly And Company India Pvt Ltd
The FDA refused shipment AEK-0046386-8/10003/1 from Eli Lilly And Company India Pvt Ltd (India) on Mar 27, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Mar 27, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75